American Renal Associates Holdings, Inc. Announces Third Quarter 2016 Earnings Release Date and Conference Call
BEVERLY, Mass.--(BUSINESS WIRE)--
American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider
of dialysis services, announced today that it will release its third
quarter 2016 financial results after the market close on Thursday,
November 10, 2016, to be followed by a conference call on Friday,
November 11, 2016 at 9:00 a.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing (877)
407-8029, or for international callers (201) 689-8029. A replay will be
available one hour after the call and can be accessed by dialing (877)
660-6853, or for international callers (201) 612-7415. The conference ID
for the live call and the replay is 13645757. The replay will be
available until November 18, 2016.
Interested investors and other parties may also listen to a simultaneous
webcast of the conference call by logging onto the Investor Relations
section of the company’s website at http://ir.americanrenal.com/.
The online replay will be available for a limited time beginning
immediately after the call.
About American Renal Associates
American Renal Associates
Holdings, Inc. (NYSE: ARA) is a leading provider of outpatient dialysis
services in the United States. As of June 30, 2016, ARA operated 201
dialysis clinic locations in 25 states and the District of Columbia
serving approximately 13,750 patients with end stage renal disease. ARA
operates exclusively through a physician partnership model, in which it
partners with 369 local nephrologists to develop, own and operate
dialysis clinics. ARA’s Core Values emphasize taking good care of
patients, providing physicians with clinical autonomy and operational
support, hiring and retaining the best possible staff and providing best
practices management services. For more information about American Renal
Associates, visit www.americanrenal.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161107006372/en/
American Renal Associates Holdings, Inc.
978-922-3080 x 134
SVP of Strategy & Investor Relations
Source: American Renal Associates Holdings, Inc.